Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 465, Issue 1-2, 2000, Pages 101-111

  Pluth, Janice M ^a   Ramsey, Marilyn J ^b   Tucker, James D ^b  

^a STANFORD UNIVERSITY   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Chromosome aberrations; CYP 1A1; Maternal smoking; Newborns

Indexed keywords

ACYLTRANSFERASE; CIGARETTE SMOKE; CYTOCHROME P450; DEBRISOQUINE 4 HYDROXYLASE; EPOXIDE HYDROLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; ISOENZYME;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; METABOLIC ACTIVATION; NEWBORN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; SMOKING; UMBILICAL CORD BLOOD;

ACETYLTRANSFERASES; ADOLESCENT; ADULT; CARCINOGENS, ENVIRONMENTAL; CHROMOSOME ABERRATIONS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL BLOOD; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; POLYMORPHISM, GENETIC; PREGNANCY; QUESTIONNAIRES; SMOKING;

NICOTIANA TABACUM;

EID: 0034673259     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00217-X     Document Type: Article

References (46)

1. B. Binkova, J. Lewtas, I. Miskova, P. Rossner, M. Cerna, G. Mrackova, K. Peterkova, J. Mumford, S. Meyer, R. Sram, Biomarker studies in Northern Bohemia, Environ. Health Perspect. 104 (1996) 591-597.
2. U. Cartensen, A. Alexandrie, B. Hogstedt, A. Rannug, I. Bratt, L. Hagmar, B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu), Mutat. Res. 289 (1993) 187-195.
3. G. van Poppel, H. Verhagen, P. van't Veer, P. van Bladeren, Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione s-transferase μ, Cancer Epidemiol., Biomarkers Prev. 2 (1993) 441-447.
4. D. Vlachodimitropoulos, H. Norppa, K. Autio, J. Catalan, A. Hirvonen, G. Tasa, M. Uuskula, N. Demopoulos, M. Sorsa, GSTT1 dependent induction of centromere-negative and -positive micronuclei by l,2:3,4-diepoxybutane in cultured human lymphocytes, Mutagenesis 12 (1997) 397-403.
5. M. Ichiba, L. Hagmar, A. Rannug, B. Hogstedt, A. Alexandrie, C.U.K. Hemminki, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps, Carcinogenesis 15 (1994) 1347-1352.
6. R. Scarpato, L. Migliore, A. Hirvonen, G. Falck, H. Norppa, Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1, and NAT2 genotypes, Environ. Mol. Mutagen. 27 (1996) 263-269.
7. G.C. Falck, A. Hirvonen, R. Scarpato, S.T. Saarikoski, L. Migliore, H. Norppa, Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1, and NAT2 in pesticide-exposed greenhouse workers, Mutat. Res. 441 (1999) 225-237.
8. T. Cheng, D. Christiani, X. Xu, J. Wain, J. Wiencke, K. Kelsey, Increased micronucleus frequency in lymphocytes from smokers with lung cancer, Mutat. Res. 349 (1996) 43-50.
9. G. van Poppel, N. de Vogel, P.J. van Balderen, F.J. Kok, Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu, Carcinogenesis 13 (1992) 303-305.
10. M. Sorsa, K. Husgafvel-Pursiainen, H. Jarventaus, K. Koskimies, H. Salo, H. Vainio, Cytogenetic effects of tobacco smoke exposure among involuntary smokers, Mutat. Res. 222 (1989) 111-116.
11. M. Sorsa, S. Osterman-Golkar, K. Peltonen, S.T. Saarikoski, R. Sram, Assessment of exposure to butadiene in the process industry, Toxicology 113 (1996) 77-83.
12. R. Scarpato, A. Hirvonen, L. Migliore, G. Falck, H. Norppa, Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers, Mutat. Res. 389 (1997) 227-235.
13. B. Binkova, J. Topinka, G. Mrackova, D. Gajdosova, P. Vidova, L. Dobias, V. Peterka, I. Kalina, R.J. Sram, Biomarkers in humans exposed to polycyclic aromatic hydrocarbons, Environ. Mol. Mutagen. 29 (1997) S5.
14. S.Z. Abdel-Rahman, R.A. El-Zein, J.B. Zwishchenberger, W.W. Au, Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers, Mutat. Res. 398 (1998) 43-54.
15. N. Conforti-Froes, R. el-Zein, S.Z. Abdel-Rahman, J.B. Zwischenberger, W.W. Au, Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers, Mutat. Res. 379 (1997) 53-59.
16. M.J. Ramsey, D.H. Moore, J.F. Briner, D.A. Lee, L.A. Olsen, J.R. Senft, J.D. Tucker, The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting, Mutat. Res. 338 (1995) 95-106.
17. A.A. Fryer, L. Zhao, J. Alldersea, M.D. Boggild, C.W. Perrett, R.N. Clayton, P.W. Jones, R.C. Strange, The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas, Carcinogenesis 14 (1993) 563-566.
18. S. Pemble, K.R. Schroeder, S.R. Spencer, D.J. Meyer, E. Hallier, H.M. Bolt, B. Ketterer, J.B. Taylor, Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism, Biochem. J. 300 (1994) 271-276.
19. L.W. Harries, M.J. Stubbins, D. Forman, G.C.W. Howard, C.R. Wolf, Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer, Carcinogenesis 18 (1997) 641-644.
20. A.C. Deitz, M.A. Doll, D.W. Hein, A restriction fragment length polymorphism assay that differentiates human Nacetyltransferases-1 (NAT1) alleles, Anal. Bio. 253 (1998) 219-224.
21. M. Doll, A. Fretland, A. Deity, D. Hein, Determination of human NAT2 acetylator genotype by restriction fragmentlength polymorphism and allele-specific amplification, Anal. Biochem. 231 (1995) 413-420.
22. V.M. Steen, O.A. Andreassen, A.K. Daly, T. Tefre, A. Borresen, J.R. Idle, A. Gulbrandsen, Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology, Pharmacogenetics 5 (1995) 215-223.
23. C.B. Ambrosone, J.L. Freudenheim, S. Graham, J.R. Marshall, J.E. Vena, J.R. Brasure, R. Laughlin, T. Nemoto, A.M. Michalek, A. Harrington, T.D. Ford, P.G. Shields, Cytochrome P4501A1 and glutathione S-transferase (Ml) genetic polymorphisms and postmenopausal breast cancer risk, Cancer Res. 55 (1995) 3483-3485.
24. P.C. Rumsby, A. Yardley-Jones, D. Anderson, H.E. Phillimore, M.J. Davies, Detection of CYP1A1 mRNA levels and CYP1A1 MspI polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers, Teratog., Carcinog., Mutagen. 16 (1996) 65-74.
25. J. Brockmoller, I. Cascorbi, R. Kerb, I. Roots, Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione G-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk, Cancer Res. 56 (1996) 3915-3925.
26. C. Hassett, L. Aicher, J.S. Sidhu, C.J. Omiecinski, Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants, Hum. Mol. Genet. 3 (1994) 421-428.
27. J. Lucas, T. Tenjin, T. Straume, D. Pinkel, D. Moore II, M. Litt, J. Gray, Rapid human chromosome aberration analysis using fluorescence in situ hybridization, Int. J. Radiat. Biol. 56 (1989) 35-44.
28. M. Mendelsohn, B. Mayall, E. Bogart, D.I. Moore, B. Perry, DNA content and DNA-based centromeric index of the 24 human chromosomes, Science 179 (1973) 1126-1129.
29. S. Hayashi, J. Watanabe, K. Kawajiri, High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes, Jpn. J. Cancer Res. 83 (1992) 866-870.
30. K. Kawajiri, J. Watanabe, H. Eguchi, S. Hayashi, Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility, Pharmacogenetics 5 (1995) 70-73.
31. X. Xu, K.T. Kelsey, J.K. Wiencke, J.C. Wain, D.C. Christiani, Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility, Cancer Epidemiol. Biomarkers Prev. 5 (1996) 687-692.
32. R.M. Whyatt, D.A. Bell, W. Jedrychowski, R.M. Santella, S.J. Garte, G. Cosma, D.K. Manchester, T. Young, T.B. Cooper, R. Ottman, F.P. Perera, Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype, Carcinogenesis 19 (1998) 1389-1392.
33. R.M. Whyatt, R.M. Santella, W. Jedrychowski, S.J. Garte, D.A. Bell, R. Ottman, A. Gladek-Yarborough, G. Cosma, T. Young, T.B. Cooper, M.C. Randall, D.K. Manchester, F.P. Perera, Relationship between ambient air pollution and DNA damage in Polish mothers and newborns, Env. Health Perspect. 106 (1998) 821-826.
34. J. Berger, E. Wynder, The correlation of epidemiological variables, J. Clin. Epid. 47 (1994) 941-952.
35. J. Baranowski, G. Pochopie'n, I. Baranowska, Determination of nicotine, cotinine and caffeine in meconium using highperformance liquid chromatography, J. Chromatogr., B: Biomed. Sci. Appl. 707 (1998) 317-321.
36. G. Lackmann, U. Salzberger, U. Tollner, M. Chen, S. Carmella, S. Hecht, Metabolites of a tobacco-specific carcinogen in urine from newborns, J. Natl. Cancer Inst. 91 (1999) 459-465.
37. 32P-postlabeling procedure, Environ. Health Perspect. 99 (1993) 229-231.
38. R. Seshadri, E. Baker, P. Leonard, G. Sutherland, A. Morley, Sister chromatid exchange in aplastic anemia, Cancer Genet. Cytogenet. 3 (1981) 81-84.
39. G. Ardito, L. Lamberti, Sister chromatid exchanges in cigarette smoking human females and their newborns, Mutat. Res. 78 (1980) 209-212.
40. M. Lundberg, G. Livingston, Sister-chromatid exchange frequency in lymphocytes of smoking and nonsmoking mothers and their newborn infants, Mutat. Res. 121 (1983) 241-246.
41. S. Sardas, B. Karahalil, D. Akyol, S. Kukner, A. Karakaya, The effect of smoking on sister chromatid exchange rate of newborn infants born to smoking mothers, Mutat. Res. 341 (1995) 249-253.
42. K. Salonen, J. Lahdetie, No effect of maternal smoking in early pregnancy observed on chromosome aberrations in chorionic villus samples, Mutat. Res. 298 (1993) 285-289.
43. M.M. Ammenheuser, A.B. Berenson, N.J. Stiglich, E.J. Whorton, J.J. Ward, Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns, Mutat. Res. 304 (1994) 285-294.
44. M.M. Ammenheuser, A.B. Berenson, A.E. Babiak, C.R. Singleton, E.B. Whorton Jr., Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns, Mutat. Res. 403 (1998) 55-64.
45. B.A. Finette, T. Poseno, P.M. Vacek, R.J. Albertini, The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the hprt locus in healthy newborns, Mutat. Res. 377 (1997) 115-123.
46. B. Finette, J.P. O'Neill, P.M. Vacek, R.J. Albertini, Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke, Nat. Med. 4 (1998) 1144-1151.